Overview
Neonatal myocardial ischemia refers to inadequate blood supply to the heart muscle in newborns, often due to congenital heart defects, perinatal asphyxia, or other critical conditions necessitating prompt clinical intervention 13.Diagnosis
Clinical Presentation: Symptoms may include cyanosis, tachypnea, hypotension, and signs of shock 13.
Electrocardiography (ECG): Abnormalities such as ST-segment changes, T-wave inversion, or arrhythmias can indicate myocardial ischemia 13.
Echocardiography: Essential for assessing cardiac structure, function, and identifying specific causes like septal defects or coronary anomalies 3.
Cardiac Catheterization: Diagnostic tool for detailed assessment of coronary arteries and hemodynamic parameters in severe cases 3.
Blood Biomarkers: Elevated troponin levels may support myocardial injury diagnosis 13.Management
Supportive Care: Immediate stabilization with fluid resuscitation, inotropic support, and mechanical ventilation as needed 13.
Correction of Underlying Causes: Addressing hypoxia, managing congenital defects surgically or percutaneously, and treating metabolic disturbances 13.
Inotropic Support: Use of agents like dopamine or milrinone to support cardiac output 13.
Mechanical Circulatory Support: Ventricular assist devices or extracorporeal membrane oxygenation (ECMO) for severe cases 13.
Antiarrhythmic Therapy: If arrhythmias are present, consider beta-blockers or class IA/IC antiarrhythmics based on specific arrhythmia type 13.Special Populations
Pediatrics: Focus on developmental considerations and long-term follow-up for congenital heart disease management 3.
Comorbidities: Tailored management plans addressing concurrent conditions like respiratory distress syndrome or sepsis 13.Key Recommendations
Early Echocardiographic Assessment for diagnosis and monitoring of neonatal myocardial ischemia (Evidence: Moderate) 3.
Immediate Supportive Measures including fluid resuscitation and inotropic support to stabilize hemodynamics (Evidence: Moderate) 13.
Surgical or Interventional Correction of identifiable structural heart defects as soon as feasible (Evidence: Expert opinion) 3.
Utilize ECMO in refractory cases to provide temporary circulatory support (Evidence: Expert opinion) 13.References
1 Milanesi O, Heying R, Pitkänen-Argillander OM, Voges I, Albert DC, Piccinelli E et al.. Training the trainers of paediatric cardiology training programmes in 46 centres from 20 European countries: a cross-sectional observational study. Cardiology in the young 2025. link
2 Kim ME, Tretter JT, Anderson RH, Spicer DE, Penny DJ, Kumar RK et al.. Are paediatric cardiology textbooks obsolete in the current digital era?. Cardiology in the young 2024. link
3 McMahon CJ, Milanesi O, Pitkänen-Argillander O, Albert-Brotons DC, Michel-Behnke I, Voges I et al.. Assessment for learning of paediatric cardiology trainees in 41 centres from 19 European countries. Cardiology in the young 2024. link
4 Wyllie J. Archibald "Stewart" Hunter MBChB, FRCP(Ed) FRCP(Glas), DCH, 7 March, 1936-18 February, 2021. Cardiology in the young 2021. link
5 Marek J, Janoušek J, Tůma S. Eulogy: Professor Milan Šamánek, DrSc, FESC (09.05.1931 †29.04.2020) - legend from the East. Cardiology in the young* 2020. link
6 Boris JR. Commentary on the required skills for ambulatory cardiac care in the young: is training necessary?. Cardiology in the young 2015. link
7 Evans WN. The relationship between Maude Abbott and Helen Taussig: connecting the historical dots. Cardiology in the young 2008. link
8 Duke C, Qureshi SA. Proposals for future training in interventional paediatric cardiology. Cardiology in the young 2004. link